Abstract: A touch detection device that includes: a steering body; a sensor electrode provided at the steering body and having an electrostatic capacitance; and a measurement control section configured to: measure the electrostatic capacitance of the sensor electrode over a measurement cycle according to a measurement frequency and to output a detection value according to values measured by setting the measurement frequency to 50 Hz or 60 Hz for removal target frequencies of 50 Hz and 60 Hz, set the measurement cycle and a period for calculating a segment average of the measurement values based on the measurement frequency, and set an interval between adjacent averaging segments for calculating the segment average such that one segment average value is suppressed by another segment average value for 50 Hz and 60 Hz frequency components, and output an averaged measurement value for the two averaging segments as the detection value.

Abstract: A compound having anticancer activity, or a pharmaceutically acceptable salt thereof is provided. Used is a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: (wherein, L1 and L2 are the same or different and each represents a group represented by one formula selected from the group consisting of formulas (A) to (F), and S represents a group represented by one formula selected from the group consisting of formulas (S1) to (S18)).

Abstract: A compound having anticancer activity, or a pharmaceutically acceptable salt thereof is provided. Used is a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: (wherein, L1 and L2 are the same or different and each represents a group represented by one formula selected from the group consisting of formulas (A) to (F), and S represents a group represented by one formula selected from the group consisting of formulas (S1) to (S18)).

Abstract: A compound having anticancer activity, or a pharmaceutically acceptable salt thereof is provided. Used is a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: (wherein, L1 and L2 are the same or different and each represents a group represented by one formula selected from the group consisting of formulas (A) to (F), and S represents a group represented by one formula selected from the group consisting of formulas (S1) to (S18)).

Abstract: A compound having anticancer activity, or a pharmaceutically acceptable salt thereof is provided. Used is a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: (wherein, L1 and L2 are the same or different and each represents a group represented by one formula selected from the group consisting of formulas (A) to (F), and S represents a group represented by one formula selected from the group consisting of formulas (S1) to (S18)).